147 related articles for article (PubMed ID: 3137763)
1. Comparison between IVF and GIFT using the GnRH agonist protocol.
Cittadini E; Palermo R; Agrifoglio V
Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
4. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
[TBL] [Abstract][Full Text] [Related]
7. Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios?
Yang JH; Wu MY; Chao KH; Chen SU; Ho HN; Yang YS
J Reprod Med; 1997 Oct; 42(10):663-8. PubMed ID: 9350023
[TBL] [Abstract][Full Text] [Related]
8. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
9. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
10. [Use of a technic of bioluminescence for determining estrogens and LH during static and dynamic study of the ovary].
Cristol P; Alameddine S; Terouanne B; Nicolas JC; Arnal F; Hedon B; Crastes de Paulet A
Ann Biol Clin (Paris); 1989; 47(4):167-80. PubMed ID: 2502049
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles.
Mohamed KA; Davies WA; Lashen H
Fertil Steril; 2007 Feb; 87(2):433-5. PubMed ID: 17094983
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence, significance and therapy of premature LH rise and peak in the In Vitro Fertilization program].
Urbancsek J; Csömör S; Benno R; Thomas R; Sztanyik L; Klaus G
Orv Hetil; 1990 Apr; 131(17):905-9. PubMed ID: 2111900
[TBL] [Abstract][Full Text] [Related]
13. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
Ferrari B; Barusi L; Coppola F
J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
[TBL] [Abstract][Full Text] [Related]
14. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
[TBL] [Abstract][Full Text] [Related]
15. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.
Merviel P; Antoine JM; Mathieu E; Millot F; Mandelbaum J; Uzan S
Fertil Steril; 2004 Jul; 82(1):119-25. PubMed ID: 15236999
[TBL] [Abstract][Full Text] [Related]
17. [In vitro fertilization and embryo transfer].
Saito H; Nakagawa K; Kojima R; Takahashi Y
Nihon Rinsho; 2006 Apr; 64 Suppl 4():80-4. PubMed ID: 16689289
[No Abstract] [Full Text] [Related]
18. Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists.
Macnamee MC; Howles CM; Edwards RG
Hum Reprod; 1987 Oct; 2(7):569-71. PubMed ID: 3119660
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone (LH) surge in patients using buserelin spray during ovarian stimulation for assisted reproduction.
Ho PC; Chan YF; So WK; Yeung WS; Chan ST
Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):159-63. PubMed ID: 8379863
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.
Karimzadeh MA; Mashayekhy M; Mohammadian F; Moghaddam FM
Arch Gynecol Obstet; 2011 May; 283(5):1159-64. PubMed ID: 21221982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
